{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:49:17Z","timestamp":1787618957021,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770428"],"award-info":[{"award-number":["81770428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830010"],"award-info":[{"award-number":["81830010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900438"],"award-info":[{"award-number":["81900438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18411950400"],"award-info":[{"award-number":["18411950400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.yjmcc.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:08:09Z","timestamp":1623985689000},"page":"91-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation"],"prefix":"10.1016","volume":"159","author":[{"given":"Yejiao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruosen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2021.06.009_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.yjmcc.2021.06.009_bb0015","article-title":"Novel regulators and drug targets of cardiac hypertrophy","volume":"28","author":"Finckenberg","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0020","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","article-title":"Heart failure","volume":"365","author":"McMurray","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2016.04.020","article-title":"Gamma-linolenic acid, dihommo-gamma linolenic, eicosanoids and inflammatory processes","volume":"785","author":"Sergeant","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.yjmcc.2021.06.009_bb0030","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.3390\/ijms21239020","article-title":"Effect of prostanoids on human platelet function: an overview","volume":"21","author":"Braune","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.intimp.2016.04.021","article-title":"Prostaglandin-E1 has a protective effect on renal ischemia\/reperfusion-induced oxidative stress and inflammation mediated gastric damage in rats","volume":"36","author":"Gezginci-Oktayoglu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0040","first-page":"716","article-title":"Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension","volume":"11","author":"Murali","year":"1992","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1054\/plef.2002.0429","article-title":"Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1","volume":"67","author":"Weiss","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0003319719865670","article-title":"Alprostadil and contrast-induced nephropathy","volume":"71","author":"Kumar","year":"2020","journal-title":"Angiology."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2008.12.173","article-title":"Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration","volume":"146","author":"Serra","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00395-012-0295-z","article-title":"Prostaglandin E1 facilitates inotropic effects of 5-HT4 serotonin receptors and \u03b2-adrenoceptors in failing human heart","volume":"107","author":"Riise","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/oxfordjournals.eurheartj.a015235","article-title":"Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results","volume":"18","author":"Pacher","year":"1997","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","article-title":"Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload","volume":"120","author":"Takeda","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0075","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCRESAHA.114.302476","article-title":"The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0080","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/00007890-199712150-00002","article-title":"Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells","volume":"64","author":"Natori","year":"1997","journal-title":"Transplantation."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0021-9150(96)06025-X","article-title":"Inhibitory effect of prostaglandin E1 on intimal thickening following photochemically induced endothelial injury in the rat femoral artery","volume":"130","author":"Umemura","year":"1997","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0090","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1038\/sj.emboj.7600454","article-title":"Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein","volume":"23","author":"Pradervand","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0095","doi-asserted-by":"crossref","first-page":"172941","DOI":"10.1016\/j.ejphar.2020.172941","article-title":"MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK\/STAT and MAPK signaling pathways","volume":"872","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0100","first-page":"1820","article-title":"Role of the lysyl oxidase enzyme family in cardiac function and disease","volume":"115","author":"Da","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0105","first-page":"1447","article-title":"Identification of differentially expressed genes and preliminary validations in cardiac pathological remodeling induced by transverse aortic constriction","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/thno.22196","article-title":"Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update","volume":"8","author":"Suthahar","year":"2018","journal-title":"Theranostics."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fphar.2019.00465","article-title":"A CRM1 inhibitor alleviates cardiac hypertrophy and increases the nuclear distribution of NT-PGC-1\u03b1 in NRVMs","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-8741(97)01526-2","article-title":"Effect of Maharishi AK-4 on H2O2-induced oxidative stress in isolated rat hearts","volume":"56","author":"Cullen","year":"1997","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2014.06.018","article-title":"Extracellular signal-regulated kinase activation during cardiac hypertrophy reduces sarcoplasmic\/endoplasmic reticulum calcium ATPase 2 (SERCA2) transcription","volume":"75","author":"Huang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2015.10.078","article-title":"Cardiomyocyte specific expression of Acyl-coA thioesterase 1 attenuates sepsis induced cardiac dysfunction and mortality","volume":"468","author":"Xia","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0135","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3892\/mmr.2016.4755","article-title":"Netrin-1 prevents the development of cardiac hypertrophy and heart failure","volume":"13","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0140","doi-asserted-by":"crossref","first-page":"11884","DOI":"10.1038\/ncomms11884","article-title":"Loss of the RNA-binding protein TACO1 causes late-onset mitochondrial dysfunction in mice","volume":"7","author":"Richman","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0145","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1128\/MCB.00950-07","article-title":"Protein kinase A, Ca2+\/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes","volume":"27","author":"Faul","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0150","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1096\/fj.201701455RR","article-title":"Cardiac fibroblast-specific p38\u03b1 MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism","volume":"32","author":"Bageghni","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.lfs.2018.08.039","article-title":"Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt\/GSK3\u03b2\/mTOR pathways","volume":"209","author":"Chen","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0160","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","article-title":"SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy","volume":"136","author":"Tang","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0165","article-title":"The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction","author":"Withaar","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0175","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E receptors","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0180","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/pr.112.007195","article-title":"The prostanoid EP4 receptor and its signaling pathway","volume":"65","author":"Yokoyama","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0185","doi-asserted-by":"crossref","first-page":"14656","DOI":"10.1038\/ncomms14656","article-title":"Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction","volume":"8","author":"Tang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0190","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.RES.81.5.765","article-title":"Expression, function, and regulation of E-type prostaglandin receptors (EP3) in the nonischemic and ischemic pig heart","volume":"81","author":"Hohlfeld","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1074248416642520","article-title":"Knockout of the prostaglandin E receptor subtype 3 promotes eccentric cardiac hypertrophy and fibrosis in mice","volume":"22","author":"Liu","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0200","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1161\/ATVBAHA.112.254052","article-title":"Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility","volume":"32","author":"Chen","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0205","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.274.5290.1123","article-title":"The molecular biology of axon guidance","volume":"274","author":"Tessier-Lavigne","year":"1996","journal-title":"Science."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0210","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.1000435","article-title":"Netrin-1 regulates Th1\/Th2\/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury","volume":"185","author":"Tadagavadi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.1683","article-title":"Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia","volume":"10","author":"Rosenberger","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0220","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.yjmcc.2009.11.020","article-title":"Netrin-1 prevents ischemia\/reperfusion-induced myocardial infarction via a DCC\/ERK1\/2\/eNOS s1177\/NO\/DCC feed-forward mechanism","volume":"48","author":"Zhang","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0225","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1089\/scd.2011.0475","article-title":"Cytoprotective and proangiogenic activity of ex-vivo netrin-1 transgene overexpression protects the heart against ischemia\/reperfusion injury","volume":"21","author":"Durrani","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0230","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/s41467-019-13476-9","article-title":"Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice","volume":"10","author":"Ni","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0235","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1074\/jbc.M115.683052","article-title":"Thromboxane A2 receptor inhibition suppresses multiple myeloma cell proliferation by inducing p38\/c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK)-mediated G2\/M progression delay and cell apoptosis","volume":"291","author":"Liu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI62839","article-title":"Signaling effectors underlying pathologic growth and remodeling of the heart","volume":"123","author":"van Berlo","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0245","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.106.679589","article-title":"Mitogen-activated protein kinases in heart development and diseases","volume":"116","author":"Wang","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.yjmcc.2021.06.009_bb0250","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41556-020-0483-2","article-title":"Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling","volume":"22","author":"Huyghe","year":"2020","journal-title":"Nat. Cell Biol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:00:22Z","timestamp":1762668022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282821001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S0022282821001310"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.009","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}